Black Diamond Therapeutics, Inc.
NASDAQ:BDTX
1.72 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 36.437 | 56.221 | 34.315 | 65.799 | 34.605 | 154.666 | 51.66 | 7.878 |
| Short Term Investments
| 62.138 | 75.179 | 88.492 | 143.987 | 280.462 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 98.575 | 131.4 | 122.807 | 209.786 | 315.067 | 154.666 | 51.66 | 7.878 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.601 | 2.634 | 4.899 | 5.917 | 4.487 | 2.096 | 0.024 | 0.036 |
| Total Current Assets
| 101.176 | 134.034 | 127.706 | 209.786 | 319.554 | 154.666 | 51.684 | 7.914 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 20.396 | 23.71 | 27.381 | 30.74 | 8.787 | 0.164 | 0.134 | 0.102 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.168 | 1.223 | 1.223 | 0.055 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.068 | 0.823 | 0 | 5.933 | 0.106 | 3.41 | 0.008 | 0.005 |
| Total Non-Current Assets
| 21.464 | 24.533 | 28.549 | 37.896 | 10.116 | 3.629 | 0.142 | 0.107 |
| Total Assets
| 122.64 | 158.567 | 156.255 | 247.682 | 329.67 | 158.295 | 51.826 | 8.021 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 4.007 | 2.324 | 1.877 | 4.107 | 2.538 | 1.964 | 0.416 | 0.152 |
| Short Term Debt
| 0 | 3.113 | 2.841 | 0.32 | 1.047 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 16.566 | 14.209 | 10.543 | 19.215 | 10.633 | 2.899 | 2.159 | 2.078 |
| Total Current Liabilities
| 20.573 | 19.646 | 15.261 | 23.642 | 14.218 | 4.863 | 2.575 | 2.23 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 18.782 | 22.185 | 25.299 | 28.14 | 7.694 | 0 | 60.77 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 200.589 | 4.023 | 12.466 |
| Total Non-Current Liabilities
| 18.782 | 22.185 | 25.299 | 28.14 | 7.694 | 200.589 | 64.793 | 12.466 |
| Total Liabilities
| 39.355 | 41.831 | 40.56 | 491.502 | 21.912 | 209.265 | 67.368 | 14.696 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 329.67 | 200.573 | 60.77 | 12.458 |
| Common Stock
| 0.007 | 0.007 | 0.005 | 0.005 | 0.005 | 0.001 | 0.001 | 0.001 |
| Retained Earnings
| -487.107 | -417.431 | -334.989 | -243.82 | -118.224 | -50.97 | -15.712 | -6.781 |
| Accumulated Other Comprehensive Income/Loss
| 0.024 | -0.027 | -1.824 | -0.414 | 0.614 | -0.001 | -0.1 | -0.056 |
| Other Total Stockholders Equity
| 570.361 | 534.187 | 452.503 | 440.129 | 95.693 | -196.761 | -60.401 | -12.241 |
| Total Shareholders Equity
| 83.285 | 116.736 | -334.989 | -243.82 | -118.224 | -50.97 | -15.542 | -6.675 |
| Total Equity
| 83.285 | 116.736 | -334.989 | -243.82 | -118.224 | -50.97 | -15.542 | -6.675 |
| Total Liabilities & Shareholders Equity
| 122.64 | 158.567 | -294.429 | 247.682 | -96.312 | 158.295 | 51.826 | 8.021 |